Accustem Sciences Inc. (ACUT) shareholders
ACUTOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.15+0.00 (0.00%)
Close on Oct 16, 2026Market cap $2.37MP/E –Yield –
Ownership
Who owns Accustem Sciences's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Gabriele M. Cerrone | Director, 10% owner | 6,502,400 | 40.46% | Jun 16, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Gabriele M. Cerrone Director, 10% owner | Jun 13, 2025 | Buy | +400 | $1.10 | $440 | 6,502,400 |
| Gabriele M. Cerrone Director, 10% owner | Jun 13, 2025 | Buy | +2,000 | $1.00 | $2.00K | 6,502,000 |
| Gabriele M. Cerrone Director, 10% owner | Jun 12, 2025 | Buy | +8,991 | $0.83 | $7.46K | 6,500,000 |
| Gabriele M. Cerrone Director, 10% owner | Jun 11, 2025 | Buy | +28,205 | $0.39 | $11.00K | 6,491,009 |
| Gabriele M. Cerrone Director, 10% owner | Apr 9, 2025 | Buy | +3,000 | $0.67 | $2.01K | 4,910,759 |
| Gabriele M. Cerrone Director, 10% owner | Apr 8, 2025 | Buy | +35,000 | $0.67 | $23.45K | 4,907,759 |
| Gabriele M. Cerrone Director, 10% owner | Apr 7, 2025 | Buy | +17,802 | $0.61 | $10.86K | 4,837,759 |
| Gabriele M. Cerrone Director, 10% owner | Apr 7, 2025 | Buy | +35,000 | $0.65 | $22.75K | 4,872,759 |
| Gabriele M. Cerrone Director, 10% owner | Mar 18, 2025 | Buy | +100,000 | $0.45 | $45.00K | 4,819,957 |
| Gabriele M. Cerrone Director, 10% owner | Dec 31, 2024 | Buy | +100,000 | $0.38 | $38.00K | 4,719,957 |
| Gabriele M. Cerrone Director, 10% owner | Dec 30, 2022 | Buy | +5,000 | $1.40 | $7.00K | 3,864,452 |
| Gabriele M. Cerrone Director, 10% owner | Dec 2, 2022 | Buy | +3,729 | $1.42 | $5.30K | 3,859,452 |
| Gabriele M. Cerrone Director, 10% owner | Nov 18, 2022 | Buy | +24,500 | $1.05 | $25.73K | 3,855,723 |
| Gabriele M. Cerrone Director, 10% owner | Aug 1, 2022 | Buy | +10,000 | $0.79 | $7.90K | 3,831,223 |
| Gabriele M. Cerrone Director, 10% owner | Jun 8, 2022 | Buy | +20,000 | $0.50 | $10.00K | 3,821,226 |
| Gabriele M. Cerrone Director, 10% owner | Apr 26, 2022 | Buy | +5,266 | $1.49 | $7.85K | 3,801,226 |
| Gabriele M. Cerrone Director, 10% owner | Apr 25, 2022 | Buy | +4,181 | $1.35 | $5.64K | 3,795,960 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
0.0%
From 0M shares
Short volume, 0 days
–
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Accustem Sciences's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.
See a number that looks wrong?